Don’t let good research go bad with a sloppy strategy. Think smarter with these tips to get every go-to-market plan in tip-top shape with faster data, quality care, and early clinical evidence.
1. Set the destination, but plan for detours.
For a smart kickoff strategy, you’ll need to keep tabs on more than you might think. For example, do you fully understand the genetic makeup of a patient’s tumor and what makes your drug a match? Will you enroll patients with that same genetic context?
You’ll also need to plan for every scenario and adapt your trial design in real-time based on the data. Ask yourself:
- Are you considering all variables?
- What about relevant models or missed biomarkers?
- What story will the data tell?
- What if the evidence takes you somewhere unexpected?
2. Build checkpoints into your trial.
It’s not just about the start, the middle and the end—it’s about all the mile markers in between. So, add intermediary goals to measure performance in real-time. That way, you can track progress for the many things a sound clinical strategy needs, like advanced diagnostics, comprehensive medical imaging and genetic targeting.
3. Assess and adapt in real-time.
Strategies can (and should) change in real-time. Go where the science takes you, and if that means you consider clinical sites, patient populations or indications you hadn’t thought of before, go for it. More nimble strategies make for the best clinical outcomes, so don’t be afraid to adapt as you go.
Ready to create your clinical strategy? Fast-track your research with TD2 and get the peace of mind of working with a partner who navigates the complexities of drug development to guide you down the smarter path.
